As shown by the increased IVIS luminescence detection, overexpression of ERα in A549 cells can increase the tumor growth, which can be reduced by CCR2 antagonist, CXCR4 antagonist AMD3100, or anti‐estrogen fulvestrant in vivo (Fig. 8A). Here, ESR1 is linked to neoplasm.